{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:28:43Z","timestamp":1792614523919,"version":"4.5.0"},"reference-count":231,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03059-8","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:46:35Z","timestamp":1759945595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nano-phytochemical-based formulations as promising opportunities for prostate cancer therapy and management: a comprehensive narrative review"],"prefix":"10.1007","volume":"42","author":[{"given":"Mohammad Amin","family":"Bakhshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Sheikhzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ramezanimoladehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Pourkamalzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Sheikhzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"5","key":"3059_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","volume":"18","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 2021;18(5):282\u2013301.","journal-title":"Nat Rev Urol"},{"issue":"17\u201318","key":"3059_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17\u201318):1105\u201340.","journal-title":"Genes Dev"},{"issue":"9","key":"3059_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091455","volume":"10","author":"BP George","year":"2021","unstructured":"George BP, Chandran R, Abrahamse H. Role of phytochemicals in cancer chemoprevention: insights. Antioxidants. 2021;10(9):1455.","journal-title":"Antioxidants"},{"key":"3059_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/md20080466","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Alam W, Jeandet P, Aschner M, Alsharif KF, Saso L, et al. Therapeutic potential of marine peptides in prostate cancer: mechanistic insights. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20080466.","journal-title":"Mar Drugs"},{"issue":"1","key":"3059_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02023-5","volume":"7","author":"AN Singh","year":"2017","unstructured":"Singh AN, Baruah MM, Sharma N. Structure based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against prostate cancer. Sci Rep. 2017;7(1):1955.","journal-title":"Sci Rep"},{"key":"3059_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12199-018-0724-1","volume":"23","author":"A Kapinova","year":"2018","unstructured":"Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, et al. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med. 2018;23:1\u201318.","journal-title":"Environ Health Prev Med"},{"issue":"7","key":"3059_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073571","volume":"22","author":"B Kim","year":"2021","unstructured":"Kim B, Park J-E, Im E, Cho Y, Lee J, Lee H-J, et al. Recent advances in nanotechnology with nano-phytochemicals: molecular mechanisms and clinical implications in cancer progression. Int J Mol Sci. 2021;22(7):3571.","journal-title":"Int J Mol Sci"},{"key":"3059_CR8","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N, et al. Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. Int J Nanomed. 2024;19:5837\u201358.","journal-title":"Int J Nanomed"},{"key":"3059_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109745","volume":"351","author":"P Kumar","year":"2022","unstructured":"Kumar P, Yadav N, Chaudhary B, Jain V, Balaramnavar VM, Alharbi KS, et al. Promises of phytochemical based nano drug delivery systems in the management of cancer. Chem Biol Interact. 2022;351:109745.","journal-title":"Chem Biol Interact"},{"issue":"22","key":"3059_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee S-Y, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3059_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63.","journal-title":"World J Oncol"},{"issue":"12","key":"3059_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"13","key":"3059_CR13","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.7314\/APJCP.2015.16.13.5137","volume":"16","author":"MN Bashir","year":"2015","unstructured":"Bashir MN. Epidemiology of prostate cancer. Asian Pac J Cancer Prev. 2015;16(13):5137\u201341.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"3059_CR14","first-page":"805","volume":"19","author":"ZQ Tao","year":"2015","unstructured":"Tao ZQ, Shi AM, Wang KX, Zhang WD. Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol Sci. 2015;19(5):805\u201312.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"3059_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/iju.13593","volume":"25","author":"T Kimura","year":"2018","unstructured":"Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524\u201331.","journal-title":"Int J Urol"},{"key":"3059_CR16","first-page":"17","volume-title":"The etiology of prostate cancer","author":"KL Ng","year":"2021","unstructured":"Ng KL. The etiology of prostate cancer. Brisbane City: Exon Publications; 2021. p. 17\u201327."},{"issue":"2","key":"3059_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nu13020496","volume":"13","author":"M Oczkowski","year":"2021","unstructured":"Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, W\u0142odarek D, Gromadzka-Ostrowska J. Dietary factors and prostate cancer development, progression, and reduction. Nutrients. 2021;13(2):496.","journal-title":"Nutrients"},{"key":"3059_CR18","volume-title":"Seminars in oncology","author":"R Schrecengost","year":"2013","unstructured":"Schrecengost R, Knudsen KE. Molecular pathogenesis and progression of prostate cancer. In: Seminars in oncology. Amsterdam: Elsevier; 2013."},{"key":"3059_CR19","first-page":"68","volume-title":"Molecular pathology","author":"WB Coleman","year":"2018","unstructured":"Coleman WB. Molecular pathogenesis of prostate cancer. In: Molecular pathology. Amsterdam: Elsevier; 2018. p. 68\u2013555."},{"issue":"5","key":"3059_CR20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2741\/4443","volume":"21","author":"H Chen","year":"2016","unstructured":"Chen H, Zhou L, Wu X, Li R, Wen J, Sha J, et al. The PI3K\/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed). 2016;21(5):1084\u201391.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3059_CR21","volume-title":"Seminars in nuclear medicine","author":"M Nguyen-Nielsen","year":"2016","unstructured":"Nguyen-Nielsen M, Borre M. Diagnostic and therapeutic strategies for prostate cancer. In: Seminars in nuclear medicine. Amsterdam: Elsevie; 2016."},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"0129","DOI":"10.34133\/cbsystems.0129","volume":"5","author":"K Li","year":"2024","unstructured":"Li K, Wang Q, Tang X, Akakuru OU, Li R, Wang Y, et al. Advances in prostate cancer biomarkers and probes. Cyborg Bionic Syst. 2024;5:0129.","journal-title":"Cyborg Bionic Syst"},{"issue":"1","key":"3059_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","volume":"17","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17(1):41\u201361.","journal-title":"Nat Rev Urol"},{"issue":"13","key":"3059_CR24","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-14-3334","volume":"21","author":"GH Leyten","year":"2015","unstructured":"Leyten GH, Hessels D, Smit FP, Jannink SA, de Jong H, Melchers WJ, et al. Identification of a candidate gene panel for the early diagnosis of prostate cancer. Clin Cancer Res. 2015;21(13):3061\u201370.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3059_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo MY, Rathkopf DE, Kantoff P. Treatment of advanced prostate cancer. Annu Rev Med. 2019;70(1):479\u201399.","journal-title":"Annu Rev Med"},{"key":"3059_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans AJ. Treatment effects in prostate cancer. Mod Pathol. 2018;31:110\u201321.","journal-title":"Mod Pathol"},{"key":"3059_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105996","volume":"100","author":"D Modi","year":"2024","unstructured":"Modi D, Hussain MS, Ainampudi S, Prajapati BG. Long acting injectables for the treatment of prostate cancer. J Drug Deliv Sci Technol. 2024;100:105996.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"3059_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrclinonc.2011.72","volume":"8","author":"G Di Lorenzo","year":"2011","unstructured":"Di Lorenzo G, Buonerba C, Kantoff PW. Immunotherapy for the treatment of prostate cancer. Nat Rev Clin Oncol. 2011;8(9):551\u201361.","journal-title":"Nat Rev Clin Oncol"},{"key":"3059_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2021.06.010","volume":"519","author":"Y Yamada","year":"2021","unstructured":"Yamada Y, Beltran H. The treatment landscape of metastatic prostate cancer. Cancer Lett. 2021;519:20\u20139.","journal-title":"Cancer Lett"},{"key":"3059_CR30","doi-asserted-by":"publisher","DOI":"10.34133\/research.0371","volume":"7","author":"N Wu","year":"2024","unstructured":"Wu N, Zhang X, Fang C, Zhu M, Wang Z, Jian L, et al. Progesterone enhances Niraparib efficacy in ovarian cancer by promoting palmitoleic-acid-mediated ferroptosis. Research. 2024;7:0371.","journal-title":"Research"},{"issue":"2","key":"3059_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000444063","volume":"23","author":"C Leitzmann","year":"2016","unstructured":"Leitzmann C. Characteristics and health benefits of phytochemicals. Complement Med Res. 2016;23(2):69\u201374.","journal-title":"Complement Med Res"},{"issue":"1\/2","key":"3059_CR32","first-page":"1","volume":"9","author":"D Koche","year":"2016","unstructured":"Koche D, Shirsat R, Kawale M. An overerview of major classes of phytochemicals: their types and role in disease prevention. Hislopia J. 2016;9(1\/2):1\u201311.","journal-title":"Hislopia J"},{"issue":"5\u20136","key":"3059_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/19396368.2022.2074325","volume":"68","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wang C, Wang K, He C, Hu K, Liang M. The effects and molecular mechanism of heat stress on spermatogenesis and the mitigation measures. Syst Biol Reprod Med. 2022;68(5\u20136):331\u201347.","journal-title":"Syst Biol Reprod Med"},{"issue":"12","key":"3059_CR34","doi-asserted-by":"publisher","first-page":"21138","DOI":"10.3390\/molecules201219753","volume":"20","author":"Y-J Zhang","year":"2015","unstructured":"Zhang Y-J, Gan R-Y, Li S, Zhou Y, Li A-N, Xu D-P, et al. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015;20(12):21138\u201356.","journal-title":"Molecules"},{"issue":"6","key":"3059_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/10408398.2019.1601848","volume":"59","author":"J Xiao","year":"2019","unstructured":"Xiao J, Bai W. Bioactive phytochemicals. Crit Rev Food Sci Nutr. 2019;59(6):827\u20139.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"3059_CR36","first-page":"84","volume":"5","author":"A Hosseini","year":"2015","unstructured":"Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015;5(2):84.","journal-title":"Avicenna J Phytomed"},{"issue":"7","key":"3059_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/nu11071483","volume":"11","author":"B Salehi","year":"2019","unstructured":"Salehi B, Fokou PVT, Yamthe LRT, Tali BT, Adetunji CO, Rahavian A, et al. Phytochemicals in prostate cancer: from bioactive molecules to upcoming therapeutic agents. Nutrients. 2019;11(7):1483.","journal-title":"Nutrients"},{"key":"3059_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1746-1596-9-98","volume":"9","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhang C, Yang X, Yang B, Wang J, Kang Y, et al. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer. Diagn Pathol. 2014;9:98.","journal-title":"Diagn Pathol"},{"issue":"3","key":"3059_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/pros.10089","volume":"51","author":"TC Hour","year":"2002","unstructured":"Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Pu YS. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1\/CIP1) and C\/EBPbeta expressions and suppressing NF-kappaB activation. Prostate. 2002;51(3):211\u20138.","journal-title":"Prostate"},{"key":"3059_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118455","volume":"191","author":"M Ramezanimoladehi","year":"2025","unstructured":"Ramezanimoladehi M, Sheikhzadeh S, Delirezh N. Synergistic apoptotic effects of berberine and hesperidin co-encapsulated in PLGA nanoparticles on lymph node carcinoma of prostate cell line. Biomed Pharmacother. 2025;191:118455.","journal-title":"Biomed Pharmacother"},{"issue":"51","key":"3059_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.17944\/interdiscip.1297112","volume":"15","author":"Y Erzurumlu","year":"2024","unstructured":"Erzurumlu Y, \u00c7atakl\u0131 D, Do\u011fan HK. Curcumin synergistically augments the chemotherapeutic activity of doxorubicin in prostate cancer cells. Interdiscip Med J. 2024;15(51):10\u20139.","journal-title":"Interdiscip Med J"},{"key":"3059_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.biopha.2016.12.138","volume":"88","author":"J Yan","year":"2017","unstructured":"Yan J, Wang Y, Jia Y, Liu S, Tian C, Pan W, et al. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomed Pharmacother. 2017;88:374\u201383.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3059_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-2.16096","volume":"43","author":"A Ayyildiz","year":"2021","unstructured":"Ayyildiz A, Koc H, Turkekul K, Erdogan S. Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K\/PTEN\/AKT pathway in prostate cancer cells. Exp Oncol. 2021;43(2):125\u201334.","journal-title":"Exp Oncol"},{"key":"3059_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.msec.2016.11.006","volume":"71","author":"A Arya","year":"2017","unstructured":"Arya A, Ahmad H, Tulsankar S, Agrawal S, Mittapelly N, Boda R, et al. Bioflavonoid hesperetin overcome bicalutamide induced toxicity by co-delivery in novel SNEDDS formulations: optimization, in vivo evaluation and uptake mechanism. Mater Sci Eng C Mater Biol Appl. 2017;71:954\u201364.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"12","key":"3059_CR45","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.31557\/APJCP.2021.22.12.3823","volume":"22","author":"SA El-Benhawy","year":"2021","unstructured":"El-Benhawy SA, Morsi MI, Fahmy EI, Soula MA, Khalil F, Arab AR. Role of resveratrol as radiosensitizer by targeting cancer stem cells in radioresistant prostate cancer cells (PC-3). Asian Pac J Cancer Prev. 2021;22(12):3823\u201337.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"3059_CR46","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1158\/1535-7163.MCT-16-0515","volume":"15","author":"E Mukhtar","year":"2016","unstructured":"Mukhtar E, Adhami VM, Siddiqui IA, Verma AK, Mukhtar H. Fisetin enhances chemotherapeutic effect of cabazitaxel against human prostate cancer cells. Mol Cancer Ther. 2016;15(12):2863\u201374.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"3059_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1039\/C7BM01201B","volume":"6","author":"G Wang","year":"2018","unstructured":"Wang G, Zhang D, Yang S, Wang Y, Tang Z, Fu X. Co-administration of genistein with doxorubicin-loaded polypeptide nanoparticles weakens the metastasis of malignant prostate cancer by amplifying oxidative damage. Biomater Sci. 2018;6(4):827\u201335.","journal-title":"Biomater Sci"},{"key":"3059_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111035","volume":"114","author":"AA Shitole","year":"2020","unstructured":"Shitole AA, Sharma N, Giram P, Khandwekar A, Baruah M, Garnaik B, et al. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs docetaxel and quercetin for prostate cancer. Mater Sci Eng, C. 2020;114:111035.","journal-title":"Mater Sci Eng, C"},{"issue":"1","key":"3059_CR49","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/21691401.2018.1489271","volume":"47","author":"M Hemati","year":"2019","unstructured":"Hemati M, Haghiralsadat F, Yazdian F, Jafari F, Moradi A, Malekpour-Dehkordi Z. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artif Cells Nanomed Biotechnol. 2019;47(1):1295\u2013311.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3059_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189966","author":"J Rutz","year":"2021","unstructured":"Rutz J, Benchellal A, Kassabra W, Maxeiner S, Bernd A, Kippenberger S, et al. Growth, proliferation and metastasis of prostate cancer cells is blocked by low-dose curcumin in combination with light irradiation. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22189966.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3059_CR51","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/tox.23459","volume":"37","author":"K Anjaly","year":"2022","unstructured":"Anjaly K, Tiku AB. Caffeic acid phenethyl ester induces radiosensitization via inhibition of DNA damage repair in androgen-independent prostate cancer cells. Environ Toxicol. 2022;37(5):995\u20131006.","journal-title":"Environ Toxicol"},{"key":"3059_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091390","author":"SK Singh","year":"2019","unstructured":"Singh SK, Apata T, Gordetsky JB, Singh R. Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11091390.","journal-title":"Cancers (Basel)"},{"key":"3059_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106199","volume":"174","author":"L Zhang","year":"2022","unstructured":"Zhang L, Lin Z, Chen Y, Gao D, Wang P, Lin Y, et al. Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer. Eur J Pharm Sci. 2022;174:106199.","journal-title":"Eur J Pharm Sci"},{"issue":"21","key":"3059_CR54","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.3390\/molecules27217410","volume":"27","author":"MAI Alhasawi","year":"2022","unstructured":"Alhasawi MAI, Aatif M, Muteeb G, Alam MW, Oirdi ME, Farhan M. Curcumin and its derivatives induce apoptosis in human cancer cells by mobilizing and redox cycling genomic copper ions. Molecules. 2022;27(21):7410.","journal-title":"Molecules"},{"issue":"11","key":"3059_CR55","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/biom10111536","volume":"10","author":"D Termini","year":"2020","unstructured":"Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E. Curcumin against prostate cancer: current evidence. Biomolecules. 2020;10(11):1536.","journal-title":"Biomolecules"},{"issue":"5","key":"3059_CR56","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/biof.1533","volume":"45","author":"A Bhat","year":"2019","unstructured":"Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, et al. Benefits of curcumin in brain disorders. BioFactors. 2019;45(5):666\u201389.","journal-title":"BioFactors"},{"key":"3059_CR57","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1007\/s13197-016-2377-7","volume":"53","author":"S Sheikhzadeh","year":"2016","unstructured":"Sheikhzadeh S, Alizadeh M, Rezazad M, Hamishehkar H. Application of response surface methodology and spectroscopic approach for investigating of curcumin nanoencapsulation using natural biopolymers and nonionic surfactant. J Food Sci Technol. 2016;53:3904\u201315.","journal-title":"J Food Sci Technol"},{"key":"3059_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154306","volume":"104","author":"Y Cai","year":"2022","unstructured":"Cai Y, Huang C, Zhou M, Xu S, Xie Y, Gao S, et al. Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities. Phytomedicine. 2022;104:154306.","journal-title":"Phytomedicine"},{"issue":"1","key":"3059_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280112","volume":"18","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zu G, Yu Y, Tang J, Han T, Zhang C. Curcumin\u2019s mechanism of action against ischemic stroke: a network pharmacology and molecular dynamics study. PLoS ONE. 2023;18(1):e0280112.","journal-title":"PLoS ONE"},{"issue":"1","key":"3059_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13010096","volume":"13","author":"LF Laurindo","year":"2023","unstructured":"Laurindo LF, Santos ARdOd, Carvalho ACAd, Bechara MD, Guiguer EL, Goulart RdA, et al. Phytochemicals and regulation of NF-kB in inflammatory bowel diseases: an overview of in vitro and in vivo effects. Metabolites. 2023;13(1):96.","journal-title":"Metabolites"},{"key":"3059_CR61","doi-asserted-by":"publisher","first-page":"881641","DOI":"10.3389\/fonc.2022.881641","volume":"12","author":"OA Ojo","year":"2022","unstructured":"Ojo OA, Adeyemo TR, Rotimi D, Batiha GE-S, Mostafa-Hedeab G, Iyobhebhe ME, et al. Anticancer properties of curcumin against colorectal cancer: a review. Front Oncol. 2022;12:881641.","journal-title":"Front Oncol"},{"issue":"5","key":"3059_CR62","first-page":"28","volume":"28","author":"T Yuan","year":"2022","unstructured":"Yuan T, Cai D, Hu B, Zhu Y, Qin J. Therapeutic effects of curcumin on osteoarthritis and its protection of chondrocytes through the Wnt\/\u0392-catenin signaling pathway. Altern Ther Health Med. 2022;28(5):28\u201337.","journal-title":"Altern Ther Health Med"},{"issue":"12","key":"3059_CR63","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1002\/ptr.7983","volume":"37","author":"P Joshi","year":"2023","unstructured":"Joshi P, Verma K, Kumar Semwal D, Dwivedi J, Sharma S. Mechanism insights of curcumin and its analogues in cancer: an update. Phytother Res. 2023;37(12):5435\u201363.","journal-title":"Phytother Res"},{"issue":"8","key":"3059_CR64","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/antiox11081481","volume":"11","author":"Z-J Yang","year":"2022","unstructured":"Yang Z-J, Huang S-Y, Zhou D-D, Xiong R-G, Zhao C-N, Fang A-P, et al. Effects and mechanisms of curcumin for the prevention and management of cancers: an updated review. Antioxidants. 2022;11(8):1481.","journal-title":"Antioxidants"},{"key":"3059_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111119","volume":"134","author":"A Zia","year":"2021","unstructured":"Zia A, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S. The role of curcumin in aging and senescence: molecular mechanisms. Biomed Pharmacother. 2021;134:111119.","journal-title":"Biomed Pharmacother"},{"key":"3059_CR66","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1208\/s12249-017-0772-7","volume":"18","author":"P Saralkar","year":"2017","unstructured":"Saralkar P, Dash AK. Alginate nanoparticles containing curcumin and resveratrol: preparation, characterization, and in vitro evaluation against DU145 prostate cancer cell line. AAPS PharmSciTech. 2017;18:2814\u201323.","journal-title":"AAPS PharmSciTech"},{"key":"3059_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110181","volume":"127","author":"Y Chen","year":"2020","unstructured":"Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother. 2020;127:110181.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3059_CR68","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s11033-022-08208-0","volume":"50","author":"ZB Bolat","year":"2023","unstructured":"Bolat ZB, Islek Z, Sahin F, Ucisik MH. Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell. Mol Biol Rep. 2023;50(3):2531\u201343.","journal-title":"Mol Biol Rep"},{"key":"3059_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122328","author":"E Einafshar","year":"2024","unstructured":"Einafshar E, Javid H, Amiri H, Akbari-Zadeh H, Hashemy SI. Curcumin loaded \u03b2-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment. Carbohydr Polym. 2024. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122328.","journal-title":"Carbohydr Polym"},{"issue":"19","key":"3059_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194891","volume":"20","author":"S Katta","year":"2019","unstructured":"Katta S, Srivastava A, Thangapazham RL, Rosner IL, Cullen J, Li H, et al. Curcumin-gene expression response in hormone dependent and independent metastatic prostate cancer cells. Int J Mol Sci. 2019;20(19):4891.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3059_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137013","volume":"22","author":"E Bevacqua","year":"2021","unstructured":"Bevacqua E, Curcio M, Saletta F, Vittorio O, Cirillo G, Tucci P. Dextran-curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells. Int J Mol Sci. 2021;22(13):7013.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3059_CR72","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbamcr.2007.04.015","volume":"1773","author":"H-G Zhang","year":"2007","unstructured":"Zhang H-G, Kim H, Liu C, Yu S, Wang J, Grizzle WE, et al. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochimica et Biophysica Acta (BBA). 2007;1773(7):1116\u201323.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"23","key":"3059_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239275","volume":"21","author":"AV Bounegru","year":"2020","unstructured":"Bounegru AV, Apetrei C. Voltamperometric sensors and biosensors based on carbon nanomaterials used for detecting caffeic acid\u2014a review. Int J Mol Sci. 2020;21(23):9275.","journal-title":"Int J Mol Sci"},{"key":"3059_CR74","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S287280","author":"SO Ekeuku","year":"2021","unstructured":"Ekeuku SO, Pang K-L, Chin K-Y. Effects of caffeic acid and its derivatives on bone: a systematic review. Drug Des Devel Ther. 2021. https:\/\/doi.org\/10.2147\/DDDT.S287280.","journal-title":"Drug Des Devel Ther"},{"key":"3059_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.595516","volume":"11","author":"H Silva","year":"2020","unstructured":"Silva H, Lopes NMF. Cardiovascular effects of caffeic acid and its derivatives: a comprehensive review. Front Physiol. 2020;11:595516.","journal-title":"Front Physiol"},{"issue":"9","key":"3059_CR76","first-page":"552","volume":"34","author":"A Amirizadeh","year":"2023","unstructured":"Amirizadeh A, Sheikhzadeh S, Delirezh N. Anticancer effects of caffeine nanoemulsions on chronic myeloid leukemia. Stud Med Sci. 2023;34(9):552\u201364.","journal-title":"Stud Med Sci"},{"issue":"1","key":"3059_CR77","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3762\/bjnano.14.31","volume":"14","author":"AH Kurt","year":"2023","unstructured":"Kurt AH, Olutas EB, Avcioglu F, Karaku\u015f H, Sungur MA, Oztabag CK, et al. Quercetin-and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities. Beilstein J Nanotechnol. 2023;14(1):362\u201376.","journal-title":"Beilstein J Nanotechnol"},{"key":"3059_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105759","volume":"171","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, et al. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: new hope in the fight against cancer. Pharmacol Res. 2021;171:105759.","journal-title":"Pharmacol Res"},{"issue":"12","key":"3059_CR79","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1021\/acs.jnatprod.0c00350","volume":"83","author":"A Murugesan","year":"2020","unstructured":"Murugesan A, Lassalle-Claux Gg, Hogan L, Vaillancourt E, Selka A, Luiker K, et al. Antimyeloma potential of caffeic acid phenethyl ester and its analogues through Sp1 mediated downregulation of IKZF1-IRF4-MYC axis. J Nat Prod. 2020;83(12):3526\u201335.","journal-title":"J Nat Prod"},{"key":"3059_CR80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijbiomac.2022.09.084","volume":"222","author":"B Tousian","year":"2022","unstructured":"Tousian B, Ghasemi MH, Khosravi AR. Targeted chitosan nanoparticles embedded into graphene oxide functionalized with caffeic acid as a potential drug delivery system: new insight into cancer therapy. Int J Biol Macromol. 2022;222:295\u2013304.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"3059_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092370","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J, Bhargava P, Yu Y, Sari AN, Zhang H, Ishii N, et al. Novel caffeic acid phenethyl ester-mortalin antibody nanoparticles offer enhanced selective cytotoxicity to cancer cells. Cancers. 2020;12(9):2370.","journal-title":"Cancers"},{"issue":"7","key":"3059_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02784-4","volume":"42","author":"A Amirizadeh","year":"2025","unstructured":"Amirizadeh A, Sheikhzadeh S, Delirezh N. Synthesis, characterization, and evaluation of the cytotoxic effects of caffeine nanoparticles on K562 cancer cell line. Med Oncol. 2025;42(7):229.","journal-title":"Med Oncol"},{"issue":"1","key":"3059_CR83","first-page":"7274342","volume":"2020","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang J, Chang Y, Li R, Sun X, Peng L, et al. Caffeic acid phenethyl ester protects against experimental autoimmune encephalomyelitis by regulating T cell activities. Oxid Med Cell Longev. 2020;2020(1):7274342.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3059_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00797-z","volume":"29","author":"Y-K Fu","year":"2022","unstructured":"Fu Y-K, Wang B-J, Tseng J-C, Huang S-H, Lin C-Y, Kuo Y-Y, et al. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference. J Biomed Sci. 2022;29(1):16.","journal-title":"J Biomed Sci"},{"issue":"9","key":"3059_CR85","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.18632\/oncotarget.3246","volume":"6","author":"H-P Lin","year":"2015","unstructured":"Lin H-P, Lin C-Y, Huo C, Hsiao P-H, Su L-C, Jiang SS, et al. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget. 2015;6(9):6684.","journal-title":"Oncotarget"},{"issue":"22","key":"3059_CR86","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1016\/j.bmc.2013.08.057","volume":"21","author":"JT Sanderson","year":"2013","unstructured":"Sanderson JT, Clabault H, Patton C, Lassalle-Claux G, Jean-Fran\u00e7ois J, Par\u00e9 AF, et al. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells. Bioorg Med Chem. 2013;21(22):7182\u201393.","journal-title":"Bioorg Med Chem"},{"key":"3059_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138562","volume":"1312","author":"\u0130 \u0130nce","year":"2024","unstructured":"\u0130nce \u0130, Y\u0131ld\u0131r\u0131m Y, G\u00f6ker E, G\u00fcler G, Saltan F, Acar R, et al. Caffeic acid phenethyl ester (CAPE) chitosan capped ZnO nanoparticles: preparation, characterization, and its potential for the treatment of prostate cancer. J Mol Struct. 2024;1312:138562.","journal-title":"J Mol Struct"},{"issue":"14","key":"3059_CR88","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3390\/molecules25143146","volume":"25","author":"SA Almatroodi","year":"2020","unstructured":"Almatroodi SA, Almatroudi A, Khan AA, Alhumaydhi FA, Alsahli MA, Rahmani AH. Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer. Molecules. 2020;25(14):3146.","journal-title":"Molecules"},{"issue":"1","key":"3059_CR89","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jnutbio.2012.03.009","volume":"24","author":"I-T Lee","year":"2013","unstructured":"Lee I-T, Lin C-C, Lee C-Y, Hsieh P-W, Yang C-M. Protective effects of (\u2212)-epigallocatechin-3-gallate against TNF-\u03b1-induced lung inflammation via ROS-dependent ICAM-1 inhibition. J Nutr Biochem. 2013;24(1):124\u201336.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"3059_CR90","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1159\/000358702","volume":"33","author":"Z-M Wang","year":"2014","unstructured":"Wang Z-M, Gao W, Wang H, Zhao D, Nie Z-L, Shi J-Q, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-a-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. Cell Physiol Biochem. 2014;33(5):1349\u201358.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"3059_CR91","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/plants12091870","volume":"12","author":"AM Elbagory","year":"2023","unstructured":"Elbagory AM, Hull R, Meyer M, Dlamini Z. Reports of plant-derived nanoparticles for prostate cancer therapy. Plants. 2023;12(9):1870.","journal-title":"Plants"},{"issue":"1","key":"3059_CR92","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/mmr.2016.5277","volume":"14","author":"S Liu","year":"2016","unstructured":"Liu S, Xu ZL, Sun L, Liu Y, Li CC, Li HM, et al. (-)-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN. Mol Med Rep. 2016;14(1):599\u2013605.","journal-title":"Mol Med Rep"},{"issue":"1","key":"3059_CR93","first-page":"353","volume":"41","author":"VS Thakur","year":"2012","unstructured":"Thakur VS, Gupta K, Gupta S. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol. 2012;41(1):353\u201361.","journal-title":"Int J Oncol"},{"key":"3059_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154618","volume":"248","author":"A Azani","year":"2023","unstructured":"Azani A, Omran SP, Ghasrsaz H, Idani A, Kadkhodaei Eliaderani M, Peirovi N, et al. Micrornas as biomarkers for early diagnosis, targeting and prognosis of prostate cancer. Pathol-Res Pract. 2023;248:154618.","journal-title":"Pathol-Res Pract"},{"key":"3059_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","volume":"197","author":"AS Doghish","year":"2022","unstructured":"Doghish AS, Ismail A, El-Mahdy HA, Elkady MA, Elrebehy MA, Sallam A-AM. A review of the biological role of miRNAs in prostate cancer suppression and progression. Int J Biol Macromol. 2022;197:141\u201356.","journal-title":"Int J Biol Macromol"},{"key":"3059_CR96","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18502\/ijaai.v19i6.4930","volume":"4","author":"H Mokhtari","year":"2020","unstructured":"Mokhtari H, Yaghmaei B, Sirati-Sabet M, Jafari N, Mardomi A, Abediankenari S, et al. Epigallocatechin-3-gallate enhances the efficacy of MicroRNA-34a mimic and MiR-93 inhibitor co-transfection in prostate Cancer cell line. Iran J Allergy, Asthma Immunol. 2020;4:5. https:\/\/doi.org\/10.18502\/ijaai.v19i6.4930.","journal-title":"Iran J Allergy, Asthma Immunol"},{"key":"3059_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.570490","volume":"8","author":"S-L Peng","year":"2020","unstructured":"Peng S-L, Lai C-H, Chu P-Y, Hsieh J-T, Tseng Y-C, Chiu S-C, et al. Nanotheranostics with the combination of improved targeting, therapeutic effects, and molecular imaging. Front Bioeng Biotechnol. 2020;8:570490.","journal-title":"Front Bioeng Biotechnol"},{"key":"3059_CR98","doi-asserted-by":"publisher","first-page":"1119274","DOI":"10.3389\/fnut.2023.1119274","volume":"10","author":"CA Gano","year":"2023","unstructured":"Gano CA, Fatima S, Failes TW, Arndt GM, Sajinovic M, Mahns D, et al. Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines. Front Nutr. 2023;10:1119274.","journal-title":"Front Nutr"},{"key":"3059_CR99","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3389\/fonc.2019.01419","volume":"9","author":"ON Hern\u00e1ndez de la Cruz","year":"2020","unstructured":"Hern\u00e1ndez de la Cruz ON, L\u00f3pez-Gonz\u00e1lez JS, Garc\u00eda-V\u00e1zquez R, Salinas-Vera YM, Mu\u00f1iz-Lino MA, Aguilar-Cazares D, et al. Regulation networks driving vasculogenic mimicry in solid tumors. Front Oncol. 2020;9:1419.","journal-title":"Front Oncol"},{"issue":"2","key":"3059_CR100","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/ijms21020439","volume":"21","author":"C Yeo","year":"2020","unstructured":"Yeo C, Han D-S, Lee H-J, Lee E-O. Epigallocatechin-3-gallate suppresses vasculogenic mimicry through inhibiting the twist\/VE-cadherin\/AKT pathway in human prostate cancer PC-3 cells. Int J Mol Sci. 2020;21(2):439.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3059_CR101","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/nu12010092","volume":"12","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang L, Li C, Chen R, Liu C, Chen M. Lipophilized epigallocatechin gallate derivative exerts anti-proliferation efficacy through induction of cell cycle arrest and apoptosis on DU145 human prostate cancer cells. Nutrients. 2019;12(1):92.","journal-title":"Nutrients"},{"key":"3059_CR102","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.chemphyslip.2016.05.006","volume":"198","author":"R Radhakrishnan","year":"2016","unstructured":"Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, et al. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids. 2016;198:51\u201360.","journal-title":"Chem Phys Lipids"},{"issue":"27","key":"3059_CR103","doi-asserted-by":"publisher","first-page":"23880","DOI":"10.1021\/acsami.9b06155","volume":"11","author":"P-Y Chu","year":"2019","unstructured":"Chu P-Y, Tsai S-C, Ko H-Y, Wu C-C, Lin Y-H. Co-delivery of natural compounds with a dual-targeted nanoparticle delivery system for improving synergistic therapy in an orthotopic tumor model. ACS Appl Mater Interfaces. 2019;11(27):23880\u201392.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"3059_CR104","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.3390\/ijms232314669","volume":"23","author":"RJ Abdualmjid","year":"2022","unstructured":"Abdualmjid RJ, Sergi CM. Mitochondrial dysfunction and induction of apoptosis in hepatocellular carcinoma and cholangiocarcinoma cell lines by thymoquinone. Int J Mol Sci. 2022;23(23):14669.","journal-title":"Int J Mol Sci"},{"key":"3059_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1044953","volume":"11","author":"J Gao","year":"2023","unstructured":"Gao J, Kumari A, Zeng X-A, Chan S, Farooq MA, Alee M, et al. Coating of chitosan on poly D, L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer. Front Chem. 2023;11:1044953.","journal-title":"Front Chem"},{"issue":"3","key":"3059_CR106","doi-asserted-by":"publisher","first-page":"490","DOI":"10.15171\/apb.2019.058","volume":"9","author":"J Saffari Chaleshtori","year":"2019","unstructured":"Saffari Chaleshtori J, Heidari-Sureshjani E, Moradi F, Heidarian E. The effects of thymoquinone on viability, and anti-apoptotic factors (BCL-XL, BCL-2, MCL-1) in prostate cancer (PC3) cells: an in vitro and computer-simulated environment study. Adv Pharm Bull. 2019;9(3):490.","journal-title":"Adv Pharm Bull"},{"issue":"9","key":"3059_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091390","volume":"11","author":"SK Singh","year":"2019","unstructured":"Singh SK, Apata T, Gordetsky JB, Singh R. Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway. Cancers. 2019;11(9):1390.","journal-title":"Cancers"},{"issue":"9","key":"3059_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/genes14091730","volume":"14","author":"SM Osorio-P\u00e9rez","year":"2023","unstructured":"Osorio-P\u00e9rez SM, Estrada-Meza C, Ruiz-Manriquez LM, Arvizu-Espinosa MG, Srivastava A, Sharma A, et al. Thymoquinone potentially modulates the expression of key onco-and tumor suppressor miRNAs in prostate and colon cancer cell lines: insights from PC3 and HCT-15 cells. Genes. 2023;14(9):1730.","journal-title":"Genes"},{"issue":"9","key":"3059_CR109","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/cells9091976","volume":"9","author":"SK Singh","year":"2020","unstructured":"Singh SK, Gordetsky JB, Bae S, Acosta EP, Lillard JJW, Singh R. Selective targeting of the hedgehog signaling pathway by PBM nanoparticles in docetaxel-resistant prostate cancer. Cells. 2020;9(9):1976.","journal-title":"Cells"},{"issue":"6","key":"3059_CR110","first-page":"1403","volume":"68","author":"M Alshyarba","year":"2021","unstructured":"Alshyarba M, Otifi H, Al Fayi M, A Dera A, Rajagopalan P. Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt\/NF-\u03baB signaling. Biotechnol Appl Biochem. 2021;68(6):1403\u201311.","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"3059_CR111","volume":"2022","author":"S Hou","year":"2022","unstructured":"Hou S. Genistein: therapeutic and preventive effects, mechanisms, and clinical application in digestive tract tumor. Evid-Based Complement Altern Med. 2022;2022(1):5957378.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"1","key":"3059_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010035","volume":"16","author":"M Nadile","year":"2023","unstructured":"Nadile M, Kornel A, Sze NSK, Tsiani E. A comprehensive review of Genistein\u2019s effects in preclinical models of cervical cancer. Cancers. 2023;16(1):35.","journal-title":"Cancers"},{"issue":"3","key":"3059_CR113","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/cimb43030106","volume":"43","author":"SS Bhat","year":"2021","unstructured":"Bhat SS, Prasad SK, Shivamallu C, Prasad KS, Syed A, Reddy P, et al. Genistein: a potent anti-breast cancer agent. Curr Issues Mol Biol. 2021;43(3):1502\u201317.","journal-title":"Curr Issues Mol Biol"},{"key":"3059_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.851589","volume":"13","author":"X Ji","year":"2022","unstructured":"Ji X, Liu K, Li Q, Shen Q, Han F, Ye Q, et al. A mini-review of flavone isomers apigenin and genistein in prostate cancer treatment. Front Pharmacol. 2022;13:851589.","journal-title":"Front Pharmacol"},{"key":"3059_CR115","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jsbmb.2015.04.018","volume":"152","author":"AM Mahmoud","year":"2015","unstructured":"Mahmoud AM, Al-Alem U, Ali MM, Bosland MC. Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation. J Steroid Biochem Mol Biol. 2015;152:62\u201375.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"15","key":"3059_CR116","first-page":"1681","volume":"73","author":"S Zhang","year":"2013","unstructured":"Zhang S, Wang Y, Chen Z, Kim S, Iqbal S, Chi A, et al. Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. Prostate. 2013;73(15):1681\u20139.","journal-title":"Prostate"},{"issue":"3","key":"3059_CR117","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.foodchem.2013.04.109","volume":"141","author":"X Dong","year":"2013","unstructured":"Dong X, Xu W, Sikes RA, Wu C. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chem. 2013;141(3):1923\u201333.","journal-title":"Food Chem"},{"issue":"8","key":"3059_CR118","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1166\/jbn.2018.2596","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wen B, Yu H, Ding D, Zhang J, Zhang Y, et al. Berberine hydrochloride-loaded chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma. J Biomed Nanotechnol. 2018;14(8):1486\u201395.","journal-title":"J Biomed Nanotechnol"},{"key":"3059_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.01.002","volume":"448","author":"J Tian","year":"2019","unstructured":"Tian J, Guo F, Chen Y, Li Y, Yu B, Li Y. Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation. Cancer Lett. 2019;448:1\u201310.","journal-title":"Cancer Lett"},{"key":"3059_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.110966","volume":"190","author":"Y-Y Song","year":"2020","unstructured":"Song Y-Y, Yuan Y, Shi X, Che Y-Y. Improved drug delivery and anti-tumor efficacy of combinatorial liposomal formulation of genistein and plumbagin by targeting Glut1 and Akt3 proteins in mice bearing prostate tumor. Colloids Surf, B. 2020;190:110966.","journal-title":"Colloids Surf, B"},{"issue":"1","key":"3059_CR121","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/21691401.2018.1559175","volume":"47","author":"SH Ali","year":"2019","unstructured":"Ali SH, Sulaiman GM, Al-Halbosiy MM, Jabir MS, Hameed AH. Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity. Artif Cells Nanomed Biotechnol. 2019;47(1):378\u201394.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3059_CR122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00394-011-0187-2","volume":"51","author":"A Ghorbani","year":"2012","unstructured":"Ghorbani A, Nazari M, Jeddi-Tehrani M, Zand H. The citrus flavonoid hesperidin induces p53 and inhibits NF-\u03baB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPAR\u03b3-dependent mechanism. Eur J Nutr. 2012;51:39\u201346.","journal-title":"Eur J Nutr"},{"issue":"13","key":"3059_CR123","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.3390\/molecules28135152","volume":"28","author":"AH Rahmani","year":"2023","unstructured":"Rahmani AH, Babiker AY, Anwar S. Hesperidin, a bioflavonoid in cancer therapy: a review for a mechanism of action through the modulation of cell signaling pathways. Molecules. 2023;28(13):5152.","journal-title":"Molecules"},{"issue":"9","key":"3059_CR124","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/antiox11091633","volume":"11","author":"SA Jeong","year":"2022","unstructured":"Jeong SA, Yang C, Song J, Song G, Jeong W, Lim W. Hesperidin suppresses the proliferation of prostate cancer cells by inducing oxidative stress and disrupting Ca2+ homeostasis. Antioxidants. 2022;11(9):1633.","journal-title":"Antioxidants"},{"issue":"5","key":"3059_CR125","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1535370220903671","volume":"245","author":"V Aggarwal","year":"2020","unstructured":"Aggarwal V, Tuli HS, Thakral F, Singhal P, Aggarwal D, Srivastava S, et al. Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements. Exp Biol Med. 2020;245(5):486\u201397.","journal-title":"Exp Biol Med"},{"issue":"3","key":"3059_CR126","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad4221","volume":"19","author":"MA Bakhshan","year":"2024","unstructured":"Bakhshan MA, Sheikhzadeh S, Delirezh N. Hesperidin nanoparticles for prostate cancer therapy: preparation, characterization and cytotoxic activity. Biomed Mater. 2024;19(3):035044.","journal-title":"Biomed Mater"},{"issue":"23","key":"3059_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237368","volume":"26","author":"A Rauf","year":"2021","unstructured":"Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368.","journal-title":"Molecules"},{"issue":"18","key":"3059_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27185889","volume":"27","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi SA, Alsahli MA, Rahmani AH. Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules. 2022;27(18):5889.","journal-title":"Molecules"},{"issue":"11","key":"3059_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112566","volume":"15","author":"M Y\u0131ld\u0131r\u0131m","year":"2023","unstructured":"Y\u0131ld\u0131r\u0131m M, Sessevmez M, Poyraz S, D\u00fczg\u00fcne\u015f N. Recent strategies for cancer therapy: polymer nanoparticles carrying medicinally important phytochemicals and their cellular targets. Pharmaceutics. 2023;15(11):2566.","journal-title":"Pharmaceutics"},{"issue":"24","key":"3059_CR130","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.1002\/cam4.1411","volume":"9","author":"RA Rather","year":"2020","unstructured":"Rather RA, Bhagat M. Quercetin as an innovative therapeutic tool for cancer chemoprevention: molecular mechanisms and implications in human health. Cancer Med. 2020;9(24):9181\u201392.","journal-title":"Cancer Med"},{"issue":"7","key":"3059_CR131","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/cancers13071602","volume":"13","author":"Y Hussain","year":"2021","unstructured":"Hussain Y, Mirzaei S, Ashrafizadeh M, Zarrabi A, Hushmandi K, Khan H, et al. Quercetin and its nano-scale delivery systems in prostate cancer therapy: paving the way for cancer elimination and reversing chemoresistance. Cancers. 2021;13(7):1602.","journal-title":"Cancers"},{"key":"3059_CR132","doi-asserted-by":"publisher","first-page":"1121950","DOI":"10.3389\/fphar.2023.1121950","volume":"14","author":"L Koklesova","year":"2023","unstructured":"Koklesova L, Jakubikova J, Cholujova D, Samec M, Mazurakova A, \u0160udomov\u00e1 M, et al. Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management\u2014targeting cancer stem cells in the framework of predictive, preventive, personalized medicine. Front Pharmacol. 2023;14:1121950.","journal-title":"Front Pharmacol"},{"issue":"9","key":"3059_CR133","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1039\/C5NR08966B","volume":"8","author":"J Zhao","year":"2016","unstructured":"Zhao J, Liu J, Wei T, Ma X, Cheng Q, Huo S, et al. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo. Nanoscale. 2016;8(9):5126\u201338.","journal-title":"Nanoscale"},{"issue":"1","key":"3059_CR134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.32604\/or.2023.042228","volume":"32","author":"A Wahi","year":"2024","unstructured":"Wahi A, Bishnoi M, Raina N, Singh MA, Verma P, Gupta PK, et al. Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment. Oncol Res. 2024;32(1):19.","journal-title":"Oncol Res"},{"key":"3059_CR135","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.2147\/IJN.S204443","volume":"9","author":"VC Thipe","year":"2019","unstructured":"Thipe VC, Panjtan Amiri K, Bloebaum P, Raphael Karikachery A, Khoobchandani M, Katti KK, et al. Development of resveratrol-conjugated gold nanoparticles: Interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. Int J Nanomed. 2019;9:4413\u201328. https:\/\/doi.org\/10.2147\/IJN.S204443.","journal-title":"Int J Nanomed"},{"issue":"6","key":"3059_CR136","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jsps.2018.03.009","volume":"26","author":"AM Nassir","year":"2018","unstructured":"Nassir AM, Shahzad N, Ibrahim IA, Ahmad I, Md S, Ain MR. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi Pharm J. 2018;26(6):876\u201385.","journal-title":"Saudi Pharm J"},{"issue":"10","key":"3059_CR137","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1021\/mp400342f","volume":"10","author":"V Sanna","year":"2013","unstructured":"Sanna V, Siddiqui IA, Sechi M, Mukhtar H. Resveratrol-loaded nanoparticles based on poly (epsilon-caprolactone) and poly (d, l-lactic-co-glycolic acid)\u2013poly (ethylene glycol) blend for prostate cancer treatment. Mol Pharm. 2013;10(10):3871\u201381.","journal-title":"Mol Pharm"},{"issue":"1","key":"3059_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37796-w","volume":"9","author":"NA Razak","year":"2019","unstructured":"Razak NA, Abu N, Ho WY, Zamberi NR, Tan SW, Alitheen NB, et al. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Sci Rep. 2019;9(1):1514.","journal-title":"Sci Rep"},{"issue":"1","key":"3059_CR139","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpha.2020.04.002","volume":"11","author":"MS Tousi","year":"2021","unstructured":"Tousi MS, Sepehri H, Khoee S, Farimani MM, Delphi L, Mansourizadeh F. Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines. J Pharm Anal. 2021;11(1):108\u201321.","journal-title":"J Pharm Anal"},{"key":"3059_CR140","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijbiomac.2018.12.003","volume":"125","author":"C Feng","year":"2019","unstructured":"Feng C, Yuan X, Chu K, Zhang H, Ji W, Rui M. Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy. Int J Biol Macromol. 2019;125:700\u201310.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3059_CR141","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ph16020196","volume":"16","author":"RM Kumar","year":"2023","unstructured":"Kumar RM, Kumar H, Bhatt T, Jain R, Panchal K, Chaurasiya A, et al. Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics. Pharmaceuticals. 2023;16(2):196.","journal-title":"Pharmaceuticals"},{"key":"3059_CR142","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijbiomac.2016.01.082","volume":"86","author":"P Ghosh","year":"2016","unstructured":"Ghosh P, Roy AS, Chaudhury S, Jana SK, Chaudhury K, Dasgupta S. Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. Int J Biol Macromol. 2016;86:408\u201317.","journal-title":"Int J Biol Macromol"},{"key":"3059_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105423","volume":"93","author":"RH Awadeen","year":"2024","unstructured":"Awadeen RH, Boughdady MF, Zaghloul RA, Elsaed WM, Hashim IIA, Meshali MM. Plausible role of oral Fisetin-loaded chitosan oligosaccharide nanoparticles in amelioration of benign prostatic hypertrophy: in vitro and in vivo assessments. J Drug Deliv Sci Technol. 2024;93:105423.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3059_CR144","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ijms20061305","volume":"20","author":"B Salehi","year":"2019","unstructured":"Salehi B, Venditti A, Sharifi-Rad M, Kr\u0119giel D, Sharifi-Rad J, Durazzo A, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20(6):1305.","journal-title":"Int J Mol Sci"},{"key":"3059_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1247-3","volume":"38","author":"M-H Chien","year":"2019","unstructured":"Chien M-H, Lin Y-W, Wen Y-C, Yang Y-C, Hsiao M, Chang J-L, et al. Targeting the SPOCK1-snail\/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. J Exp Clin Cancer Res. 2019;38:1\u201317.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3059_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020457","volume":"12","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12(2):457.","journal-title":"Nutrients"},{"issue":"16","key":"3059_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163988","volume":"14","author":"NB Kumar","year":"2022","unstructured":"Kumar NB, Hogue S, Pow-Sang J, Poch M, Manley BJ, Li R, Dhillon J, Yu A, Byrd DA. Effects of green tea catechins on prostate cancer chemoprevention: the role of the gut microbiome. Cancers. 2022 Aug 18;14(16):3988.","journal-title":"Cancers"},{"key":"3059_CR148","doi-asserted-by":"crossref","unstructured":"Perletti, G., Magri, V., Vral, A., Stamatiou, K. and Trinchieri, A., 2019. Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis. Archivio Italiano di Urologia e Andrologia, 91(3).","DOI":"10.4081\/aiua.2019.3.153"},{"issue":"11","key":"3059_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26113260","volume":"26","author":"Y-H Lin","year":"2021","unstructured":"Lin Y-H, Wang C-C, Lin Y-H, Chen B-H. Preparation of catechin nanoemulsion from oolong tea leaf waste and its inhibition of prostate cancer cells DU-145 and tumors in mice. Molecules. 2021;26(11):3260.","journal-title":"Molecules"},{"issue":"13","key":"3059_CR150","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.3390\/ijms22137178","volume":"22","author":"MJ N\u00fa\u00f1ez-Iglesias","year":"2021","unstructured":"N\u00fa\u00f1ez-Iglesias MJ, Novio S, Garc\u00eda C, P\u00e9rez-Mu\u00f1uzuri ME, Mart\u00ednez M-C, Santiago J-L, et al. Co-adjuvant therapy efficacy of catechin and procyanidin B2 with docetaxel on hormone-related cancers in vitro. Int J Mol Sci. 2021;22(13):7178.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3059_CR151","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.3390\/ijms23126594","volume":"23","author":"G Fontana","year":"2022","unstructured":"Fontana G, Badalamenti N, Bruno M, Castiglione D, Notarbartolo M, Poma P, et al. Synthesis, in vitro and in silico analysis of new oleanolic acid and lupeol derivatives against leukemia cell lines: involvement of the NF-\u03baB pathway. Int J Mol Sci. 2022;23(12):6594.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3059_CR152","doi-asserted-by":"publisher","first-page":"134","DOI":"10.6026\/97320630018134","volume":"18","author":"M Gunasekaran","year":"2022","unstructured":"Gunasekaran M, Ravi R, Subramanian K. Molecular docking analysis of lupeol with different cancer targets. Bioinformation. 2022;18(3):134.","journal-title":"Bioinformation"},{"issue":"1","key":"3059_CR153","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40199-022-00436-w","volume":"30","author":"F Malekinejad","year":"2022","unstructured":"Malekinejad F, Kheradmand F, Khadem-Ansari MH, Malekinejad H. Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells. DARU J Pharm Sci. 2022;30(1):103\u201315.","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"3059_CR154","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40203-022-00131-3","volume":"10","author":"SK Maurya","year":"2022","unstructured":"Maurya SK, Fatma H, Maurya AK, Mishra N, Siddique HR. Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, \u03b2-catenin and c-FLIP: in silico and in vitro studies. In Silico Pharmacol. 2022;10(1):16.","journal-title":"In Silico Pharmacol"},{"issue":"4","key":"3059_CR155","first-page":"364","volume":"31","author":"M Abroudi","year":"2024","unstructured":"Abroudi M, Dadashizadeh G, Shobeiri SS, Hosseini A, Gholami O, Ataee Disfani R, et al. Anti-cancer effects of Hesperidin by induction of apoptosis. J Sabzevar Univ Med Sci. 2024;31(4):364\u201377.","journal-title":"J Sabzevar Univ Med Sci"},{"issue":"1","key":"3059_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1400-z","volume":"16","author":"AB Ward","year":"2018","unstructured":"Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol. 2018;16(1):108.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"3059_CR157","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1158\/1535-7163.MCT-17-0030","volume":"16","author":"R Tummala","year":"2017","unstructured":"Tummala R, Lou W, Gao AC, Nadiminty N. Quercetin targets hnRNPA1 to overcome Enzalutamide resistance in prostate cancer cells. Mol Cancer Ther. 2017;16(12):2770\u20139.","journal-title":"Mol Cancer Ther"},{"key":"3059_CR158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2016.08.019","volume":"162","author":"S Erdogan","year":"2016","unstructured":"Erdogan S, Doganlar O, Doganlar ZB, Serttas R, Turkekul K, Dibirdik I, et al. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K\/Akt\/NF-\u03baB signaling. Life Sci. 2016;162:77\u201386.","journal-title":"Life Sci"},{"issue":"10","key":"3059_CR159","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.freeradbiomed.2008.02.007","volume":"44","author":"S Shukla","year":"2008","unstructured":"Shukla S, Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic Biol Med. 2008;44(10):1833\u201345.","journal-title":"Free Radic Biol Med"},{"key":"3059_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154860","volume":"116","author":"JC Tseng","year":"2023","unstructured":"Tseng JC, Wang BJ, Wang YP, Kuo YY, Chen JK, Hour TC, et al. Caffeic acid phenethyl ester suppresses EGFR\/FAK\/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine. 2023;116:154860.","journal-title":"Phytomedicine"},{"issue":"25","key":"3059_CR161","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.lfs.2006.07.036","volume":"79","author":"EC Stuart","year":"2006","unstructured":"Stuart EC, Scandlyn MJ, Rosengren RJ. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 2006;79(25):2329\u201336.","journal-title":"Life Sci"},{"issue":"1","key":"3059_CR162","first-page":"69","volume":"30","author":"YH Lee","year":"2012","unstructured":"Lee YH, Kwak J, Choi HK, Choi KC, Kim S, Lee J, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int J Mol Med. 2012;30(1):69\u201374.","journal-title":"Int J Mol Med"},{"key":"3059_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105906","volume":"211","author":"P Thomas","year":"2021","unstructured":"Thomas P, Dong J. (-)-Epicatechin acts as a potent agonist of the membrane androgen receptor, ZIP9 (SLC39A9), to promote apoptosis of breast and prostate cancer cells. J Steroid Biochem Mol Biol. 2021;211:105906.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"3059_CR164","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0024-3205(00)01020-1","volume":"68","author":"LY Chung","year":"2001","unstructured":"Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY, et al. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 2001;68(10):1207\u201314.","journal-title":"Life Sci"},{"key":"3059_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116699","volume":"478","author":"MA Khan","year":"2023","unstructured":"Khan MA, Singh D, Jameel M, Maurya SK, Singh S, Akhtar K, et al. Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy. Toxicol Appl Pharmacol. 2023;478:116699.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"16","key":"3059_CR166","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-11-0916","volume":"17","author":"HR Siddique","year":"2011","unstructured":"Siddique HR, Mishra SK, Karnes RJ, Saleem M. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy. Clin Cancer Res. 2011;17(16):5379\u201391.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3059_CR167","doi-asserted-by":"publisher","first-page":"535","DOI":"10.5567\/pharmacologia.2013.535.552","volume":"4","author":"A Kulhari","year":"2013","unstructured":"Kulhari A, Sheorayan A, Chaudhury A. Targeted chemotherapeutics: an overview of recent progress in effectual cancer treatment. Pharmacologia. 2013;4(9):535\u201352.","journal-title":"Pharmacologia"},{"key":"3059_CR168","first-page":"190","volume-title":"InSeminars in cancer biology","author":"SG Klochkov","year":"2021","unstructured":"Klochkov SG, Neganova ME, Nikolenko VN, Chen K, Somasundaram SG, Kirkland CE, Aliev G. Implications of nanotechnology for the treatment of cancer: Recent advances. InSeminars in cancer biology 2021 Feb 1 (Vol. 69, pp. 190-199). Academic Press."},{"issue":"1\u20132","key":"3059_CR169","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijpharm.2018.01.016","volume":"538","author":"F Dilnawaz","year":"2018","unstructured":"Dilnawaz F, Acharya S, Sahoo SK. Recent trends of nanomedicinal approaches in clinics. Int J Pharm. 2018;538(1\u20132):263\u201378.","journal-title":"Int J Pharm"},{"key":"3059_CR170","doi-asserted-by":"crossref","unstructured":"Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine in cancer. 2017:47\u201398.","DOI":"10.1201\/b22358-3"},{"issue":"18","key":"3059_CR171","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.7150\/ijms.49801","volume":"17","author":"C Jin","year":"2020","unstructured":"Jin C, Wang K, Oppong-Gyebi A, Hu J. Application of nanotechnology in cancer diagnosis and therapy-a mini-review. Int J Med Sci. 2020;17(18):2964.","journal-title":"Int J Med Sci"},{"key":"3059_CR172","doi-asserted-by":"publisher","first-page":"107","DOI":"10.32628\/IJSRST218422","volume":"8","author":"R Nath","year":"2021","unstructured":"Nath R, Roy R, Barai G, Bairagi S, Manna S, Chakraborty R. Modern developments of nano based drug delivery system by combined with phytochemicals-presenting new aspects. Int J Sci Res Sci Technol. 2021;8:107\u201329.","journal-title":"Int J Sci Res Sci Technol"},{"key":"3059_CR173","first-page":"211","volume":"2","author":"V Manickam","year":"2021","unstructured":"Manickam V, Sundar V, Panchangam RL, Amiti TR. Nanotechnology in delivery and targeting of phytochemicals. Nanopharm Princ Appl. 2021;2:211\u201364.","journal-title":"Nanopharm Princ Appl"},{"issue":"9","key":"3059_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091475","volume":"13","author":"WS Alharbi","year":"2021","unstructured":"Alharbi WS, Almughem FA, Almehmady AM, Jarallah SJ, Alsharif WK, Alzahrani NM, et al. Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics. 2021;13(9):1475.","journal-title":"Pharmaceutics"},{"key":"3059_CR175","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.foodhyd.2014.05.010","volume":"43","author":"Z Li","year":"2015","unstructured":"Li Z, Jiang H, Xu C, Gu L. A review: Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals.\nFood Hydrocolloids. 2015 Jan 1;43:153-64.","journal-title":"Food Hydrocolloids"},{"key":"3059_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-444-64185-4.00003-4","volume":"62","author":"C Enrico","year":"2019","unstructured":"Enrico C. Nanotechnology-based drug delivery of natural compounds and phytochemicals for the treatment of cancer and other diseases. Stud Nat Prod Chem. 2019;62:91\u2013123.","journal-title":"Stud Nat Prod Chem"},{"key":"3059_CR177","doi-asserted-by":"crossref","unstructured":"Barkat MA, Harshita, Das SS, Beg S, Ahmad FJ. Nanotechnology-based phytotherapeutics: current status and challenges. Nanophytomedicine: Concept to Clinic. 2020:1\u201317.","DOI":"10.1007\/978-981-15-4909-0_1"},{"key":"3059_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2024.200139","author":"D Teli","year":"2024","unstructured":"Teli D, Satasia R, Patel V, Nair R, Khatri R, Gala D, et al. Nature meets technology: harnessing nanotechnology to unleash the power of phytochemicals. Clin Tradit Med Pharmacol. 2024. https:\/\/doi.org\/10.1016\/j.ctmp.2024.200139.","journal-title":"Clin Tradit Med Pharmacol"},{"issue":"2","key":"3059_CR179","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.carbpol.2012.08.064","volume":"91","author":"R Rajendran","year":"2013","unstructured":"Rajendran R, Radhai R, Kotresh T, Csiszar E. Development of antimicrobial cotton fabrics using herb loaded nanoparticles. Carbohydr Polym. 2013;91(2):613\u20137.","journal-title":"Carbohydr Polym"},{"key":"3059_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.867655","volume":"12","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Patel AB, Mistry KJ, Suthar SF, Wu Z-X, Chen Z-S, et al. Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges. Front Oncol. 2022;12:867655.","journal-title":"Front Oncol"},{"issue":"2","key":"3059_CR181","doi-asserted-by":"publisher","first-page":"210","DOI":"10.34172\/apb.2023.023","volume":"13","author":"AR Devan","year":"2023","unstructured":"Devan AR, Nair B, Nath LR. Translational phytomedicines against cancer: promise and hurdles. Adv Pharm Bull. 2023;13(2):210.","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"3059_CR182","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","volume":"3","author":"S Senapati","year":"2018","unstructured":"Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7.","journal-title":"Signal Transduct Target Ther"},{"key":"3059_CR183","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"G Bozzuto","year":"2015","unstructured":"Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975\u201399.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3059_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","volume":"9","author":"ML Etheridge","year":"2013","unstructured":"Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed-Nanotechnol Biol Med. 2013;9(1):1\u201314.","journal-title":"Nanomed-Nanotechnol Biol Med"},{"key":"3059_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"issue":"4","key":"3059_CR186","doi-asserted-by":"publisher","first-page":"160","DOI":"10.15430\/JCP.2023.28.4.160","volume":"28","author":"K Turkekul","year":"2023","unstructured":"Turkekul K, Erdogan S. Potent suppression of prostate cancer cell growth and eradication of cancer stem cells by CD44-targeted nanoliposome-quercetin nanoparticles. J Cancer Prev. 2023;28(4):160.","journal-title":"J Cancer Prev"},{"issue":"4","key":"3059_CR187","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00210-023-02752-7","volume":"397","author":"F Khosravani","year":"2024","unstructured":"Khosravani F, Amiri F, Mahmoudi R, Morshedi D, Kobarfard F, Alipour M, et al. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(4):2347\u201357.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3059_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111723","volume":"203","author":"J-y Tian","year":"2021","unstructured":"Tian J-y, Chi C-l, Bian G, Xing D, Guo F-j, Wang X-q. PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells. Colloids Surf, B. 2021;203:111723.","journal-title":"Colloids Surf, B"},{"issue":"1","key":"3059_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.24336","volume":"125","author":"NK Narayanan","year":"2009","unstructured":"Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer. 2009;125(1):1\u20138.","journal-title":"Int J Cancer"},{"key":"3059_CR190","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00280-018-3654-0","volume":"82","author":"R Greil","year":"2018","unstructured":"Greil R, Greil-Ressler S, Weiss L, Sch\u00f6nlieb C, Magnes T, Radl B, et al. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc\u2122) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharmacol. 2018;82:695\u2013706.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"3059_CR191","doi-asserted-by":"publisher","first-page":"35","DOI":"10.22270\/jddt.v8i5.1886","volume":"8","author":"D Kaur","year":"2018","unstructured":"Kaur D, Kumar S. Niosomes: present scenario and future aspects. J Drug Deliv Ther. 2018;8(5):35\u201343.","journal-title":"J Drug Deliv Ther"},{"key":"3059_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101581","volume":"56","author":"P Bhardwaj","year":"2020","unstructured":"Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: a review on niosomal research in the last decade. J Drug Deliv Sci Technol. 2020;56:101581.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3059_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121878","volume":"624","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, Yasamineh P, Kalajahi HG, Gholizadeh O, Yekanipour Z, Afkhami H, et al. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm. 2022;624:121878.","journal-title":"Int J Pharm"},{"key":"3059_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123013","volume":"640","author":"BC Kusdemir","year":"2023","unstructured":"Kusdemir BC, Guldu OK, Kilcar AY, Medine EI. Preparation and in vitro investigation of prostate-specific membrane antigen targeted lycopene loaded niosomes on prostate cancer cells. Int J Pharm. 2023;640:123013.","journal-title":"Int J Pharm"},{"key":"3059_CR195","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S261027","author":"H Zare-Zardini","year":"2020","unstructured":"Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA, et al. Assessment of a new ginsenoside Rh2 nanoniosomal formulation for enhanced antitumor efficacy on prostate cancer: an in vitro study. Drug Des Devel Ther. 2020. https:\/\/doi.org\/10.2147\/DDDT.S261027.","journal-title":"Drug Des Devel Ther"},{"key":"3059_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2021.100082","volume":"10","author":"MP More","year":"2021","unstructured":"More MP, Pardeshi SR, Pardeshi CV, Sonawane GA, Shinde MN, Deshmukh PK, et al. Recent advances in phytochemical-based nano-formulation for drug-resistant cancer. Med Drug Discov. 2021;10:100082.","journal-title":"Med Drug Discov"},{"issue":"4","key":"3059_CR197","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4103\/japtr.JAPTR_100_20","volume":"12","author":"Y Susilawati","year":"2021","unstructured":"Susilawati Y, Chaerunisa AY, Purwaningsih H. Phytosome drug delivery system for natural cosmeceutical compounds: whitening agent and skin antioxidant agent. J Adv Pharm Technol Res. 2021;12(4):327\u201334.","journal-title":"J Adv Pharm Technol Res"},{"issue":"1","key":"3059_CR198","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/10717544.2022.2048133","volume":"29","author":"MW Al-Rabia","year":"2022","unstructured":"Al-Rabia MW, Alhakamy NA, Rizg WY, Alghaith AF, Ahmed OA, Fahmy UA. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Deliv. 2022;29(1):807\u201320.","journal-title":"Drug Deliv"},{"key":"3059_CR199","first-page":"6579","volume":"20","author":"AM Ghazi","year":"2020","unstructured":"Ghazi AM, Al-Bayati MA. Anti-proliferative of the phytosome propolis, phytosome lycopene and synergistic effect on the benign prostatic hyperplasia cells in-vitro. Plant Arch. 2020;20:6579\u201389.","journal-title":"Plant Arch"},{"issue":"4","key":"3059_CR200","first-page":"17","volume":"54","author":"A Ledda","year":"2012","unstructured":"Ledda A, Belcaro G, Dugall M, Luzzi R, Scoccianti M, Togni S, et al. Meriva\u00ae, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. Panminerva Med. 2012;54(4):17.","journal-title":"Panminerva Med"},{"issue":"6B","key":"3059_CR201","first-page":"4457","volume":"26","author":"R Agarwal","year":"2006","unstructured":"Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res. 2006;26(6B):4457\u201398.","journal-title":"Anticancer Res"},{"issue":"7","key":"3059_CR202","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/09687688.2010.516276","volume":"27","author":"RR Sawant","year":"2010","unstructured":"Sawant RR, Torchilin VP. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting. Mol Membr Biol. 2010;27(7):232\u201346.","journal-title":"Mol Membr Biol"},{"key":"3059_CR203","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336.","journal-title":"J Control Release"},{"issue":"10","key":"3059_CR204","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4155\/tde-2020-0008","volume":"11","author":"N Majumder","year":"2020","unstructured":"Majumder N, Das NG, Das SK. Polymeric micelles for anticancer drug delivery. Ther Deliv. 2020;11(10):613\u201335.","journal-title":"Ther Deliv"},{"issue":"12","key":"3059_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/polym14122510","volume":"14","author":"S Perumal","year":"2022","unstructured":"Perumal S, Atchudan R, Lee W. A review of polymeric micelles and their applications. Polymers. 2022;14(12):2510.","journal-title":"Polymers"},{"issue":"5","key":"3059_CR206","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1049\/iet-nbt.2020.0014","volume":"14","author":"R Mirsafaei","year":"2020","unstructured":"Mirsafaei R, Varshosaz J. Polyacrylamide\u2013punicic acid conjugate-based micelles for flutamide delivery in PC3 cells of prostate cancer: synthesis, characterisation and cytotoxicity studies. IET Nanobiotechnol. 2020;14(5):417\u201322.","journal-title":"IET Nanobiotechnol"},{"issue":"3","key":"3059_CR207","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jconrel.2007.04.014","volume":"122","author":"E Blanco","year":"2007","unstructured":"Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DM, Boothman DA, et al. \u0392-lapachone-containing PEG\u2013PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release. 2007;122(3):365\u201374.","journal-title":"J Control Release"},{"issue":"12","key":"3059_CR208","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2217\/nnm-2019-0443","volume":"15","author":"A Cano","year":"2020","unstructured":"Cano A, Sanchez-Lopez E, Ettcheto M, Lopez-Machado A, Espina M, Souto EB, et al. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases. Nanomedicine. 2020;15(12):1239\u201361.","journal-title":"Nanomedicine"},{"key":"3059_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111962","volume":"142","author":"S Sheikhzadeh","year":"2021","unstructured":"Sheikhzadeh S, Delirezh N, Hobbenaghi R. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer. Biomed Pharmacother. 2021;142:111962.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3059_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M, Mart\u00ednez G, Merinero M, Arg\u00fcelles-Arias F, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. 2020;10(7):1403.","journal-title":"Nanomaterials"},{"issue":"1","key":"3059_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00914037.2020.1798436","volume":"71","author":"KCd Castro","year":"2022","unstructured":"Castro KCd, Costa JM, Campos MGN. Drug-loaded polymeric nanoparticles: a review. Int J Polym Mater Polym Biomater. 2022;71(1):1\u201313.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"11","key":"3059_CR212","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1166\/jbn.2019.2854","volume":"15","author":"L Fang","year":"2019","unstructured":"Fang L, Fan H, Guo C, Cui L, Zhang P, Mu H, et al. Novel mitochondrial targeting multifunctional surface charge-reversal polymeric nanoparticles for cancer treatment. J Biomed Nanotechnol. 2019;15(11):2151\u201363.","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"3059_CR213","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/jm1013715","volume":"54","author":"V Sanna","year":"2011","unstructured":"Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, et al. Targeted biocompatible nanoparticles for the delivery of (\u2212)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem. 2011;54(5):1321\u201332.","journal-title":"J Med Chem"},{"issue":"14","key":"3059_CR214","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1080\/09205063.2024.2371186","volume":"35","author":"M Mahjoubin-Tehran","year":"2024","unstructured":"Mahjoubin-Tehran M, Rezaei S, Kesharwani P, Sahebkar A. Nanospheres for curcumin delivery as a precision nanomedicine in cancer therapy. J Biomater Sci Polym Ed. 2024;35(14):2250\u201374.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"10","key":"3059_CR215","first-page":"3867","volume":"29","author":"A Mukerjee","year":"2009","unstructured":"Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29(10):3867\u201375.","journal-title":"Anticancer Res"},{"key":"3059_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104100","volume":"80","author":"K Pearce","year":"2023","unstructured":"Pearce K, Thipe VC, Henkel RR, Katti KV. Green nanotechnology as an innovative drug delivery approach for Typha capensis and Naringenin\u2014new class of phytochemical embedded biocompatible gold nanoparticles in prostate cancer therapy. J Drug Deliv Sci Technol. 2023;80:104100.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"30","key":"3059_CR217","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","volume":"35","author":"MM Yallapu","year":"2014","unstructured":"Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, et al. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials. 2014;35(30):8635\u201348.","journal-title":"Biomaterials"},{"issue":"5","key":"3059_CR218","first-page":"1119","volume":"32","author":"RL Thangapazham","year":"2008","unstructured":"Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32(5):1119\u201323.","journal-title":"Int J Oncol"},{"issue":"2","key":"3059_CR219","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/carcin\/bgt321","volume":"35","author":"N Khan","year":"2014","unstructured":"Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, et al. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis. 2014;35(2):415\u201323.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3059_CR220","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1515\/ntrev-2022-0013","volume":"11","author":"RF Alserihi","year":"2022","unstructured":"Alserihi RF, Mohammed MRS, Kaleem M, Khan MI, Sechi M, Sanna V, et al. Development of (\u2212)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment. Nanotechnol Rev. 2022;11(1):298\u2013311.","journal-title":"Nanotechnol Rev"},{"key":"3059_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112078","volume":"124","author":"VV Vodnik","year":"2021","unstructured":"Vodnik VV, Moji\u0107 M, Stamenovi\u0107 U, Otoni\u010dar M, Ajd\u017eanovi\u0107 V, Maksimovi\u0107-Ivani\u0107 D, et al. Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines. Mater Sci Eng C Mater Biol Appl. 2021;124:112078.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"36","key":"3059_CR222","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202403869","volume":"9","author":"M Y\u0131ld\u0131r\u0131m","year":"2024","unstructured":"Y\u0131ld\u0131r\u0131m M, Acet \u00d6, \u00d6nal Acet B, Karako\u00e7 V, Odaba\u015f\u0131 M. Enhanced anti-cancer efficacy of Hesperidin through smart polymeric nanoparticles targeting prostate cancer. ChemistrySelect. 2024;9(36):e202403869.","journal-title":"ChemistrySelect"},{"issue":"3","key":"3059_CR223","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-02049-4","volume":"15","author":"A AlipourAmirabad","year":"2025","unstructured":"AlipourAmirabad A, Poorsamad A, Safari F, Moshfe A, TajaliArdakani M, Peikar A, et al. pH-sensitive peptide-modified nanoliposome containing berberine for prostate cells (DU145) targeting and anti-tumor activity. BioNanoScience. 2025;15(3):439.","journal-title":"BioNanoScience"},{"issue":"13","key":"3059_CR224","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-260","volume":"78","author":"R Kanwal","year":"2018","unstructured":"Kanwal R, Shukla S, Exner AA, Tzakos AG, Gupta S. Abstract 260: apigenin nanoparticle suppresses sphere formation in CD133+\/ALDH1high prostate cancer stem cells through downregulation of stem cell markers. Cancer Res. 2018;78(13):260-.","journal-title":"Cancer Res"},{"issue":"12","key":"3059_CR225","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/ptr.6508","volume":"33","author":"VK Singh","year":"2019","unstructured":"Singh VK, Arora D, Ansari MI, Sharma PK. Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications. Phytother Res. 2019;33(12):3064\u201389.","journal-title":"Phytother Res"},{"key":"3059_CR226","first-page":"1","volume-title":"Herbal Medicine Phytochemistry: Applications and Trends","author":"AP Gupta","year":"2024","unstructured":"Gupta AP, Pathak A, Pandey P. Challenges and Future of Nanotechnology in Global Herbal Medicine Practices. In: Herbal Medicine Phytochemistry: Applications and Trends. Cham: Springer International Publishing; 2024. p. 1\u201327."},{"issue":"3","key":"3059_CR227","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","volume":"4","author":"P Zhang","year":"2023","unstructured":"Zhang P, Xiao Y, Sun X, Lin X, Koo S, Yaremenko AV, et al. Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects. Med. 2023;4(3):147\u201367.","journal-title":"Med"},{"key":"3059_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119902","volume":"240","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Dong C, Fan W, Jiang H, Xiang J, Qiu N, et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy. Biomaterials. 2020;240:119902.","journal-title":"Biomaterials"},{"issue":"11","key":"3059_CR229","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122(11):1630\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"3059_CR230","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/nnm.13.204","volume":"9","author":"HY Xue","year":"2014","unstructured":"Xue HY, Liu S, Wong HL. Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine. 2014;9(2):295\u2013312.","journal-title":"Nanomedicine"},{"issue":"3","key":"3059_CR231","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:05:09Z","timestamp":1762427109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":231,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03059-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"510"}}